Journal of Internal Medicine 1991: Vol 229 Index

13 Pages·1991·2.5 MB·English

Journal of Internal Medicine 1991; 229: 561-566
Author Index
Aase O, see Jonsbu J et al., 143 diabetic patients: a comparison of equimolar amounts of
Abela Jr BM, see Falke P et al., 521 porcine and semi-synthetic human insulin, 293
Aberg H, see Asplund R, 131 Benestad AM, see Aursnes I et al., 325
Abildgaard U, see Andersen }5 et al., 253 Bengtsson C, see Petersen K et al., 407
Abramowicz M, see Somville JF et al., 89 Berg A-L, Hansson P & Nilsson-Ehle P. ACTH 1-24 decreases
Agbedana EO, see Ahaneku JE et al., 17 hepatic lipase activities and low density lipoprotein
Agewall S, Rhea B, Persson B, Karlberg B, Wallin G & concentrations in healthy men, 201
Andersson OK. Reflexogenic neuronal and humoral responses Berg KJ, see Holdaas Re t al., 163
to selective stimulation of low-pressure cardiopulmonary Berger M, see Sawicki PT et al., 489
receptors in man, 151 Berglund B & Ekblom B. Effect of recombinant human
Ahaneku JE, Olubuyide JO, Agbedana EO & Taylor GO. erythropoietin treatment on blood pressure and some
Changes in plasma high density lipoprotein cholesterol and haematological parameters in healthy men, 125
phospholipid in acute viral hepatitis and cholestatic jaundice, Berglund B, see Reichard Pe t al., 9
17 Berglund J, Christensen SB, Dymling JF & Hallgren B. The
Al-Mashhadani SA, see Santhosh-Kumar CR et al., 493 incidence of recurrence and hypothyroidism following
Aldershvile J, see Andersen JS et al., 253 treatment with antithyroid drugs, surgery or radioiodine in
Algotsson A, Sanz E & Alvan G. Steady-state concentrations all patients with thyrotoxicosis in Malm6 during the period
and dosage of digoxin in relation to kidney function in 1970-1974, 435
hospitalized patients over 70 years of age, 247 Bergstrém B, see Sundkvist G et al., 505
Alvan G, see Algotsson A et al., 247 Bernard E, see Dellamonica P et al., 103
Andersen JS, Egeblad H, Abildgaard U, Aldershvile J & Beswick AD, Fehily AM, Sharp DS, Renaud S & Giddings J.
Godtfredsen J. Atrial fibrillation and left atrial enlargement: Long-term diet modification and platelet activity, 511
cause or effect? 253 Bianchi Porro G, Caruso I, Petrillo M, Montrone F & Ardizzone
Andersen V, see Remvig L et al., 73 S. A double-blind gastroscopic evaluation of the effects of
Andersson OK, see Agewall S et al., 151 etodolac and naproxen on the gastrointestinal mucosa of
Andersson OK, see Widgren BR et al., 217 rheumatic patients, 5
Angelin B, see Carrella M et al., 241 Bierman EL, see Duell PB, 97
Antonini R, see Fazio S et al., 41 Binder C, see Bendtson I, 293
Araki W, Hirose S, Mimori Y, Nakamura S, Kimura J, Ohno K Binder C, see Snorgaard O et al., 343
& Shimada T. Familial hypobetalipoproteinaemia complicated Binner L, see Koenig W et al., 533
by cerebellar ataxia and steatocystoma multiplex, 197 Bisgaard C, see Sloth H et al., 443
Ardizzone S, see Bianchi Porro G et al., 5 Bjorck S, see Nassberger L et ai., 261
Ariad S, Dvilansky A, Sobel R & Nathan I. Plasma von Blychert E, see Kjellstr6m T et al., 233
Willebrand factor levels and congestive heart failure, 557 Bolinder J, see Sundkvist G et al., 61
Arnalich F, see Camacho J et al., 49 Boman K, see Jansson J-H et al., 309
Arnesen KE, see Jonsbu J et al., 143 Boman K, see Olofsson B-O et al., 55
Artur Y, see Guemouri L et al., 297 Bongiovi S, see Casiglia E et al., 501
Aspholm R, see Seppala T et al., 23 Boni M, see Casiglia E et al., 501
Asplund R & Aberg H. Diurnal variation in the levels of Boyd IW. Allopurinol-azathioprine interaction
antidiuretic hormone in the elderly, 131 Brandi L, see Thaysen JH et al., 363
Aursnes I, Benestad AM, Sivertssen E, Skjaggestad 0 & Brandtzaeg P, see Stavem P et al., 193
Gronseth K. Degree of coronary artery disease predicted by Britz A, see Reichard P et al., 9
exercise testing, 325 Brosen K, see Jensen J et al., 29
Azemoto R, see Ogawa M et al., 189 Brosstad F, see Stavem P et al., 193
Buhl M, see Ernst E et al., 457
Baehrendtz S, see Ludwigs UG et al., 117
Bakker PJM, see de Wit R et al., 35, 463, 539 Caidahl K & Kazzam E. Left ventricular hypertrophy and
Ballegaard S, Meyer CN & Trojaborg W. Acupuncture in duration of systemic sclerosis, 384
angina pectoris: does acupuncture have a specific effect? 357 Camacho J, Arnalich F, Zamorano AF & Vazquez JJ. Serum
Baralle FE, see Fazio S et al., 41 erythropoietin levels in the anaemia of chronic disorders, 49
Bassan H, see Odeh Me t al., 289 Cardoso M de FL, see Kraemer ES et al., 382
Baynes C, Henderson AD, Hughes CL, Richmond W, Johnston Carles M, see Dellamonica Pe t al., 103
DG & Elkeles RS. Determinants of mild fasting Carrella M, Ericsson S, Del Piano C, Angelin B & Einarsson K.
hypertriglyceridaemia in non-insulin-dependent diabetes, 267 Effect of cholestyramine treatment on biliary lipid secretion
Beermann B, see Sylvén C et al., 171 rates in normolipidaemic men, 241
Bendtson I & Binder C. Counterregulatory hormonal response Caruso I, see Bianchi Porro G et al., 5
to insulin-induced hypoglycaemia in insulin-dependent Casiglia E, Bongiovi S, Paleari CD, Petucco S, Boni M, Colangeli
561
562 AUTHOR INDEX
G, Penzo M & Pessina AC. Haemodynamic effects of coffee Falke P, Abela Jr BM, Krakau CET, Lilja B, Lindgarde F, Maly
and caffeine in normal volunteers: a placebo-controlled P & Stavenow L. High frequency of asymptomatic visual field
clinical study, 501 defects in subjects with transient ischaemic attacks or minor
Cederholm T, see Sylvén C et al., 171 strokes, 521
Celsing F, see Hast R et al., 381 Fauchald P, see Holdaas Re t al., 163
Christensen SB, see Berglund J et al., 435 Fazio S, Sidoli A, Vivenzio A, Maietta A, Giampaoli S, Menotti
Colangeli G, see Casiglia E et al., 501 A, Antonini R, Urbinati G, Baralle FE & Ricci G. A form of
Conn HO. Breakthroughs in ascites: effects on bottom lines, 1 familial hypobetalipoproteinaemia not due to a mutation in
Czirjak L, see Hegediis I, 383 the apolipoprotein B gene, 41
Fehily AM, see Beswick AD et al., 511
Dahlqvist SR, see Nilsson TK et al., 558 Fernandez A, see Povoa Pe t al., 475
Danielsson M, see Isaksson H et al., 421 Forde OH, see Nilssen OH, 497
Danner SA, see De Wit R et al., 35 Forsberg K, see Olofsson B-O et al., 55
De Backer G, see Renaud Se t al., 79 Fredholm BB. Diversity in receptor signalling, cellular
de Leeuw PW, see Veen C et al., 549 individuality and the search for selective drugs, 391
De Wit R, Danner SA, Bakker PJM, Lange JMA, Eeftinck Frenzel H, see Sawicki PT et al., 489
Schattenkerk JKM & Veenhof CBN. Combined zidovudine and Friedman PJ. Serum creatinine: an independent predictor of
interferon-alpha treatment in patients with AIDS-associated survival after stroke, 175
Kaposi's sarcoma, 35 Fugleholm AM, see Launbjerg J et al., 351
De Wit R, Hoek FJ, Bakker PJM & Veenhof CHN. The value of Fujita J. Negayama K, Higuchi K, Nakano M, Yamaji Y & Irino
MCA, CA 15-3, CEA and CA-125 for discrimination S. Changes in clinically separated strains of glucose non-
between metastatic breast cancer and adenocarcinoma of fermented Gram-negative bacilli following the induction of
other primary sites, 463 imipenem/cilastatin, 559
De Wit R, Raasveld MHM, ten Berge RJM, van der Wouw PA,
Bakker PJM & Veenhof CHN. Interleukin-6 concentrations in Galloe AM, Graudal N, Petersen JR, Leth P & Galloe M. The
the serum of patients with AIDS-associated Kaposi's sarcoma effect of the calcium antagonist, isradipine, on working
during treatment with interferon-alpha, 539 capacity, pulmonary function, morbidity and survival rate in
Del Piano C, see Carrella M et al., 241 patients with severe chronic obstructive pulmonary disease
Dellamonica P, Bernard E, Pradier C, Durant J, Etesse-Carsenti (COPD): a randomized, double-blind, placebo-controlled
H, Elbaze P, Mondain V & Carles M. AZT - does it prevent study, 447
occurrence of salmonelloses in AIDS patients? 103 Galloe M, see Galloe AM et al., 447
Djoseland O, see Holdaas Re t al., 163 Ganguly PK. Antioxidant therapy in congestive heart failure, 205
Ducla-Soares J, see Povoa Pe t al., 475 Gerglund G, see Widgren BR et al., 217
Duell PB & Bierman EL. Potential role of insulin in the Giampaoli S, see Fazio § et al., 41
clearance of remnant lipoproteins in dysbetalipoproteinaemia, Giddings J, see Beswick AD et al., 511
97 Gill EP, see Hayes TG et al., 467
Durant J, see Dellamonica P et al., 103 Gjorup T, see Jarlov AE et al., 159
Dvilansky A, see Ariad Se t al., 557 Godtfredsen J, see Andersen JS et al., 253
Dymling JF, see Berglund J et al., 435 Gonzalez Porque P, see Ruiz-Palomo Fe t al., 93
Grabensee B, see Plum J, 209
Edhag O, see Rasmanis G et al., 135 Grabner P, see Stavem Pe t al., 193
Eeftinck Schattenkerk JKM, see De Wit Re t al., 35 Gram LF, see Jensen J et al., 29
Egeblad H, see Andersen JS et al., 253 Grankvist K, see Olofsson B-O et al., 55
Egeblad H, see Launbjerg J et al., 351 Graudal N, see Galloe AM et al., 447
Egusa G, see Tanaka S et al., 371 Gréen K, see Rasmanis G et al., 135
Einarsson K, see Carrella M et al., 241 Gro&mann G, see Schmidt A et al., 527
Ekblom B, see Berglund B, 125 Groeneveld ABJ, see Oudkerk Pool M et al., 377
Ekfors T, see Leino R et al., 553 Grondal S, Eriksson B, Hamberger B & Theodorsson E. Plasma
Ekman M, see Hast R et al., 381 chromogranin A+B, neuropeptide Y and catecholamines in
Elbaze P, see Dellamonica P et al., 103 pheochromocytoma patients, 453
Elkeles RS, see Baynes C et al., 267 Gronseth K, see Aursnes I et al., 325
Engan T, see Hannisdal E, 337 Grove A, see Sloth H et al., 443
Ericsson S, see Carrella M et al., 241 Guemouri L, Herbeth B, Artur Y, Jeandel C. & Siest G. Weak
Ericsson U-B & Lindgiarde F. Effects of cigarette smoking on relationships between blood antioxidant enzymes and serum
thyroid function and the prevalence of goitre, thyrotoxicosis lipids or apolipoproteins, 297
and autoimmune thyroiditis, 67
Eriksen EF, see Kassem M et al., 275 Haarbo J, see Kristensen KS et al., 257
Erikssen J, see Jonsbu J et al., 143 Hallas J, see Jensen J et al., 29
Eriksson B, see Grondal S et al., 453 Hallgren B, see Berglund J et al., 435
Ernst E, see Koenig W et al., 533 Hamberg O, see Pedersen FM et al., 517
Ernst E, Resch KL, Matrai A, Buhl M, Schlosser P & Paulsen Hamberger B, see Gréndal S et al., 453
HF. Impaired blood rheology: a risk factor after stroke? 457 Hannisdal E & Engan T. Blood analyses and survival in
Etesse-Carsenti H, see Dellamonica P et al., 103 symptom- and survey-detected lung cancer patients, 337
AUTHOR INDEX 563
Hansen JM, see Jarlov AE et al., 159 Erikssen J & Koss A. Rapid and correct diagnosis of
Hansen NE, see Remvig L et al., 73 myocardial infarction: standardized case history and clinical
Hansson P, see Berg A-L et al., 201 examination provide important information for correct
Hara H, see Tanaka Se t al., 371 referral to monitored beds, 143
Hartmann A, see Holdaas R et al., 163 Jonsson O, see Widgren BR et al., 2 4
Hast R, Celsing F, Ekman M & Stenke L. Response to Joossens JV, see Renaud Se t al., 79
recombinant human erythropoietin treatment in
myelodysplastic syndromes (MDS), 381 Kaiser S, see Sawicki PT et al., 489
Hauner H, see Schmidt A et al., 527 Karlberg B, see Agewall S et al., 151
Hayes TG, Gill EP & Swarna U. Osteomyelitis of the wrist in a Karlberg J & Mossberg H-O. Weight-for-height standards in
patient with Hodgkin’s disease, 467 adulthood, 303
Hegeditis I & Czirjak L. Septum and posterior wall thickness Karle H, see Remvig L et al., 73
and disease duration in systemic sclerosis, 383 Kassem M, Eriksen EF, Melsen F & Mosekilde L. Antacid-
Hegediis L, see Jarlov AE et al., 159 induced osteomalacia: a case report with a
Hehr R, see Koenig W et al., 533 histomorphometric analysis, 275
Heinemann L, see Sawicki PT et al., 489 Kaukianen A, see Seppala T et al., 23
Henderson AD, see Baynes C et al., 267 Kazzam E, see Caidahl K, 384
Henriksson P, see Rasmanis G et al., 135 Kimura J, see Araki W et al., 197
Herbeth B, see Guemouri L et al., 297 King JC, see Rosen SD et al., 297
Herlitz H, see Widgren BR et al., 217 Kjellstr6m T, Blychert E & Lindgiirde F. Felodipine in the
Hernandez-Madrid A, Moro C, Marin Huerta E & Rayo J. treatment of hypertensive type II diabetics: effect on glucose
Third-degree atrioventricular block in an athlete, 375 homeostasis, 233
Hess K, see Pedersen FM et al., 517 Kobayashi I, see Mori M et al., 285
Higgy KE, see Santhosh-Kumar CR et al., 493 Kobayashi S, see Mori M et al., 285
Higuchi K, see Fujita J et al., 559 Koenig W, see Schmidt A et al., 527
Hildebrand IL, see Sylvén C et al., 171 Koenig W, Sund M, Ernst E, Hehr R, Binner L, Rosenthal J &
Hirose S, see Araki W et al., 197 Hombach V. Effects of felodipine ER and hydrochlorothiazide
Hoek FJ, see De Wit R et al., 463 on blood rheology in essential hypertension — a randomized,
Holdaas R, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald double-blind, cross-over study, 533
P, Djoseland O & Berg KJ. Contrasting effects of lisinopril and Konarski-Svensson JC, see Isaksson H et al., 421
nifedipine on albuminuria and tubular transport functions in Kornitzer M, see Renaud Se t al., 79
insulin-dependent diabetics with nephropathy, 163 Korpela H, see Luoma PV, 280
Hollak CEM, Prummel MF & Tiel-van Buul MMC. Bilateral Koskinen P, see Sundkvist G et al., 61
adrenal tumours in primary aldosteronism: localization of a Koss A, see Jonsbu J et al., 143
unilateral aldosteronoma by dexamethasone suppression Kraemer ES, Cardoso M de FL & Yamamura Y. Acupuncture in
scan, 545 angina pectoris, 382
Hombach V, see Koenig W et al., 533 Krakau CET, see Falke P et al., 521
Hombach V, see Schmidt A et al., 527 Kristensen KS, Haarbo J, Munkvad S & Stoltenberg M. Early
Hughes CL, see Baynes C et al., 267 thrombolytic treatment reduces analgesic requirement in
patients with myocardial infarction, 257
Irino S, see Fujita J et al., 559 Kupari M. Diastolic heart function and failure, 479
Iruchijima T, see Mori M et al., 285
Isaksson H, Danielsson M, Rosenhamer G, Konarski-Svensson Ladefoged K, see Launbjerg J et al., 351
JC & Ostergren J. Characteristics of patients resistant to Lafvas I, see Olofsson B-O et al., 55
antihypertensive drug therapy, 421 Landin K, Tengborn L & Smith U. Treating insulin resistance in
hypertension with metformin reduces both biood pressure
Jansen T, see Schmidt A et al., 527 and metabolic risk factors, 181
Janssen MJ, see Oudkerk Pool M et al., 377 Lange JMA, see De Wit R et al., 35
Jansson E, see Sylvén C et al., 171 Lapidus L, see Petersen K et al., 407
Jansson J-H, Johansson B, Boman K & Nilsson TK. Lassen LH, see Snorgaard O et al., 343
Hypofibrinolysis in patients with hypertension and elevated Launbjerg J, Egeblad H, Nielsen NH, Fugleholm AM &
cholesterol, 309 Ladefoged K. Bleeding complications to oral anticoagulant
Jarlov AE, Hegediis L, Gjorup T & Hansen JM. Observer therapy: multivariate analysis of 1010 treatment years in
variation in the clinical assessment of the thyroid gland, 159 551 outpatients, 351
Jeandel C, see Guemouri Le t al., 297 Laurberg P, Pedersen KM, Vestergaard H & Sigurdsson G. High
Jensen J, Nielsen LH, Lyhne N, Hallas J, Brosen K & Gram LF. incidence of multinodular toxic goitre in the elderly
Drugs and femoral neck fracture: a case-control study, 29 population in a low iodine intake area vs. high incidence of
Jervell J, see Holdaas R et al., 163 Graves’ disease in the young in a high iodine intake area:
Jespersen J, see Marckmann P et al., 317 comparative surveys of thyrotoxicosis epidemiology in East-
Johansson A-C, see Nassberger Le t al., 261 Jutland Denmark and Iceland, 415
Johansson B, see Jansson J-H et al., 309 Leino R, Liippo K & Ekfors T. Sulphasalazine-induced
Johnston DG, see Baynes C et al., 267 reversible hypersensitivity pneumonitis and fatal fibrosing
Jonsbu J, Rollag A, Aase O, Lippestad CT, Arnesen KE, alveolitis: report of two cases, 553
564 AUTHOR INDEX
Lenaers AP, see Somville JF et al., 89 Negayama K, see Fujita J et al., 559
Leonhardt T, see Olsson R, 471 Neve PE, see Somville JF et al., 89
Leth P. see Galloe AM et al., 447 Nielsen LH, see Jensen J et al., 29
Leth T, see Marckmann Pe t al., 317 Nielsen NH, see Launbjerg J et al., 351
Levander S, see Reichard P et al., 9 Nielsen OJ, see Thaysen JH et al., 363
Lewis B. On lowering lipids in the post-infarction patient, 483 Nilsen L, see Holdaas R et al., 163
Lien MG, see Holdaas Re t al., 163 Nilssen OH & Forde OH. The Tromso Study: the positive
Liippo K, see Leino R et al., 553 predictive value of gamma-glutamyltransferase and an
Lilja B, see Falke P et al., 521 alcohol questionnaire in the detection of early-stage risk
Lilja B, see Sundkvist G et al., 505 drinkers, 497
Lind P, see Sundkvist G et al., 505 Nilsson TK, see Jansson J-H et al., 309
Lindahl G, see Sundkvist G et al., 61 Nilsson TK, Norberg B, Wallberg-Jonsson S & Dahlqvist SR.
Lindblad R & Rédjer S. A case of severe pancytopenia caused Von Willebrand factor in plasma as risk indicator for
by ibuprofen, 281 cardiovascular events, 558
Lindgarde F, see Ericsson U-B, 67 Nilsson-Ehle P, see Berg A-L et al., 201
Lindgarde F, see Falke P et al., 521 Nixon PGF, see Rosen SD et al., 297
Lindgarde F, see Kjellstrém T et al., 233 Norberg B, see Mérnstad H, 387
Lindstedt G, see Petersen K et al., 407 Norberg B, see Nilsson TK et al., 558
Lippestad CT, see Jonsbu J et al., 143 Nordhagen R, see Stavem P et al., 193
Lithner F, see Olofsson B-O et al., 55 Nystr6m B, see Petersen K et al., 407
Ludwigs UG, Baehrendtz S, Wanecek M & Matell G.
Mechanical ventilation in medical and neurological diseases: Odeh M, Oliven A, Rauchfleisch S & Bassan H. Dilated
11 years of experience, 117 cardiomyopathy associated with Chlamydia trachomatis
Lundberg P-A, see Petersen K et al., 407 infection, 289
Luoma PV & Korpela H. Responses to the observations of Ogawa M, Azemoto R, Makino Y, Mori Y, Ueda S, Wakashin M
Guemouri et al., 280 & Ohto M. Pneumothorax in a patient with Wegener's
Lyhne N, see Jensen J et al., 29 granulomatosis during treatment with immunosuppressive
agents, 189
Maietta A, see Fazio S et al., 41 Ohno K, see Araki W et al., 197
Makino Y, see Ogawa M et al., 189 Ohshima K, see Mori M et al., 285
Maly P, see Falke P et al., 521 Ohto M, see Ogawa M et al., 189
Marckmann P, Jespersen J, Leth T & Sandstrém B. Effect of fish Okazaki M, see Tanaka Se t al., 371
diet versus meat diet on blood lipids, coagulation and Oliven A, see Odeh M et al., 289
fibrinolysis in healthy young men, 317 Olofsson B-O, Grankvist K, Olsson T, Boman K, Forsberg K,
Marin Huerta E, see Hernandez-Madrid A et al., 375 Lafvas I & Lithner F. Assessment of hypothalamic-pituitary
Matell G, see Ludwigs UG et al., 117 function in patients with familial amyloidotic
Matrai A, see Ernst E et al., 457 polyneuropathy, 55
Melsen F, see Kassem M et al., 2 / 5 Olsson R & Leonhardt T. Cholestatic liver reaction during
Menotti A, see Fazio S et al., 41 heparin therapy, 471
Meyer CN, see Ballegaard S et al., 357 Olsson T, see Olofsson B-O et al., 55
Mimori Y, see Araki W et al., 197 Olubuyide JO, see Ahaneku JE et al., 17
Mochizuki H, see Tanaka Se t al., 371 Ostergren J, see Isaksson H et al., 421
Mondain V, see Dellamonica P et al., 103 Oudkerk Pool M, Janssen MJ, van der Valk P & Groeneveld
Montrone F, see Bianchi Porro G et al., 5 ABJ. Adrenocortical insufficiency: a rare presentation of
Mori M, Shoda Y, Yamada M, Murakami M, Iruchijima T, Non-Hodgkin's lymphoma, 377
Ohshima K, Kobayashi I & Kobayashi S. Central Ovesen L, see Pedersen FM et al., 517
hypothyroidism due to isolated TRH deficiency in a
depressive man, 285 Padfield PL, see Teelucksingh § et al., 543
Mori Y, see Ogawa M et al., 189 Paleari CD, see Casiglia E et al., 501
Mornstad H & Norberg B. Cavity of ignorance, 387 Palma-Carlos AG, see Povoa P et al., 475
Moro C, see Hernandez-Madrid A et al., 375 Partinen M, see Seppala T et al., 23
Mosekilde L, see Kassem M et al., 27 5 Paulsen HF, see Ernst E et al., 457
Mossberg H-O, see Karlberg J, 303 Pedersen FM, Hamberg O, Hess K & Ovesen L. The effect of
Munkvad §, see Kristensen KS et al., 257 dietary vitamin K on warfarin-induced anticoagulation, 517
Murakami M, see Mori M et al., 285 Pedersen KM, see Laurberg P et al., 415
Pendek R, see Teelucksingh S et al., 543
Nakamura S, see Araki W et al., 197 Penttila A, see Seppala T et al., 23
Naskano M, see Fujita J et al., 559 Penzo M, see Casiglia E et al., 501
Nassberger L, Johansson A-C, Bjérck S & Sj6holm AG. Persson B, see Agewall S et al., 151
Antibodies to neutrophil granulocyte myeloperoxidase and Pessina AC, see Casiglia E et al., 501
elastase: autoimmune responses in glomerulonephritis due to Petersen JR, see Galloe AM et al., 447
hydralazine treatment, 261 Petersen K, Lindstedt G, Lundberg P-A, Bengtsson C, Lapidus L
Nathan I, see Ariad S et al., 557 & Nystrém B. Thyroid disease in middle-aged and elderly
AUTHOR INDEX 565
Swedish women: thyroid-related hormones, thyroid Prevalence of renal artery stenosis in diabetes mellitus — an
dysfunction and goitre in relation to age and smoking, 407 autopsy study, 489
Petrillo M, see Bianchi Porro G et al., 5 Schlosser P, see Ernst E et al., 457
Petucco S, see Casiglia E et al., 501 Schmidt A, GrofS{mann G, Hauner H, Koenig W, Jansen T,
Plum J & Grabensee B. Atrial natriuretic peptide in dialysis Stauch M & Hombach V. Left ventricular function and wall
patients under various conditions of volume homeostasis, thickness in long-term insulin-dependent diabetes mellitus:
209 an echocardiographic study, 527
Povoa P, Ducla-Soares J, Fernandez A & Palma-Carlos AG. A Seglen PO. Citation frequency and journal impact: valid
case of systemic mastocytosis: therapeutic efficacy of indicators of scientific quality? 109
ketotifen, 475 Seppala T, Partinen M, Penttilé A, Aspholm R, Tiainen E &
Pradier C, see Dellamonica Pe t al., 103 Kaukianen A. Sudden death and sleeping history among
Prummel MP, see Hollak CEM et al., 545 Finnish men, 23
Serrano Rios M, see Ruiz-Palomo F et al., 93
Raasveld MHM, see de Wit Re t al., 539 Sharp DS, see Beswick AD et ai., 511
Rabinowe SL, see Sundkvist G et al., 505 Sherry S. Fifty years of progress with antithrombotic drugs —
Rasmanis G, Vesterqvist O, Gréen K, Edhag O & Henriksson P. with much more to come: a perspective, 113
Prostacyclin production in myocardial infarction in the acute Shimada T, see Araki W et al., 197
phase and during follow-up, 135 Shoda Y, see Mori M et al., 285
Rauchfleisch S, see Odeh M et al., 289 Sidoli A, see Fazio S et al., 41
Rayo J, see Hernandez-Madrid A et al., 375 Siest G, see Guemouri i. et al., 297
Reichard P, Berglund B, Britz A, Levander S & Rosengqvist U. Sigurdsson G, see Laurberg P et al., 415
Hypoglycaemic episodes during intensified insulin treatment: Silfvast T. Cause of death in unsuccessful prehospital
increased frequency but no effect on cognitive function, 9 resuscitation, 331
Remvig L, Andersen V, Hansen NE & Karle H. Prophylactic Sivertssen E, see Aursnes I et al., 325
effect of self-administered pump-driven subcutaneous IgG Sjdholm AG, see Nassberger L et al., 261
infusion in patients with antibody deficiency: a triple-blind Skjzeggestad @, see Aursnes I et al., 325
cross-over study comparing P-IgG levels of 3 g 1"! versus Sloth H, Bisgaard C & Grove A. Collagenous colitis: a
egic*, 73 prospective trial of prednisolone in six patients, 443
Renaud S, see Beswick AD et al., 511 Smith U, see Landin K et al., 181
Renaud S, De Backer G, Thevenon C, Joossens JV, Vermylen J, Snorgaard O, Lassen LH, Rosenfalck AM & Binder C. Glycaemic
Kornitzer M & Verstraete M. Platelet fatty acids and function thresholds for hypoglycaemic symptoms, impairment of
in two distinct regions of Belgium: relationship to age and cognitive function, and release of counterregulatory
dietary habits, 79 hormones in subjects with functional hypoglycaemia, 343
Resch KL, see Ernst E et al., 457 Sobel R, see Ariad S et al., 557
Revilla Y, see Ruiz-Palomo F et al., 93 Somville JF, Lenaers AP, Abramowicz M & Neve PE. High
Rhea B, see Agewall S et al., 151 cardiac output as a paraneoplastic syndrome, 89
Ricci G, see Fazio S et al., 41 Stauch M, see Schmidt A et al., 527
Richmond W, see Baynes C et al., 267 Stavem P, Rorvik T, Brandtzaeg P, Brosstad F, Nordhagen R &
Rédjer S, see Lindblad R, 281 Grabner P. Gastric lymphoma causing granulocytopenia and
Rollag A, see Jonsbu J et al., 143 cold intolerance, with recovery after treatment, 193
Rorvik T, see Stavem P et al., 193 Stavenow L, see Falke P et al., 521
Rosen SD, King JC & Nixon PGF. Insensitivity of the forced Stenke L, see Hast R et al., 381
hyperventilation provocation test, 297 Stoltenberg M, see Kristensen KS et al., 257
Rosenfalck AM, see Snorgaard O et al., 343 Sund M, see Koenig W et al., 533
Rosenhamer G, see Isaksson H et al., 421 Sundkvist G, Lind P, Bergstrém B, Lilja B & Rabinowe SL.
Rosenqvist U, see Reichard P et al., 9 Autonomic nerve antibodies and autonomic nerve function
Rosenthal J, see Koenig W et al., 533 in Type 1 and Type 2 diabetic patients, 505
Rossner S. Television viewing, life style and obesity, 301 Sundkvist G, Lindahl G, Koskinen P & Bolinder J. Pancreatic
Ruiz-Palomo F, Revilla Y, Gonzalez Porque P & Serrano Rios autoantibodies and pancreatic function in Sjégren’s
M. Two IgM paraproteins bearing cryoglobulin and anti- syndrome, 61
smooth muscle activities in a patient with Waldenstrém’s Swarna U, see Hayes TG et al., 467
macroglobulinaemia, 93 Sylvén C, Jansson E, Cederholm T, Hildebrand IL & Beermann
B. Skeletal muscle depressed calcium and
Salonen JT, see Salonen R, 225 phosphofructokinase in chronic heart failure are upregulated
Salonen R & Salonen JT. Determinants of carotid intima-media by captopril—a double-blind, placebo-controlled study,
thickness: a population-based ultrasonography study in 171
Eastern Finnish men, 225 Szpirt W, see Thaysen JH et al., 363
Sandstrém B, see Marckmann P et al., 317
Santhosh-Kumar CR, Yohannan MD, Higgy KE & Takai S, see Tanaka S et al., 371
Al-Mashhadani SA. Thrombocytosis in adults: analysis of Tanaka S, Okazaki M, Egusa G, Takai S, Mochizuki H, Yamane
777 patients, 493 K, Hara H & Yamakido M. A case of pheochromocytoma
Sanz E, see Algotsson A et al., 247 associated with meningioma, 371
Sawicki PT, Kaiser S, Heinemann L, Frenzel H & Berger M. Taylor GO, see Ahaneku JE et al., 17
566 AUTHOR INDEX
Teelucksingh S, Pendek R & Padfield PL. Apathetic Veenhof CHN, see De Wit R et al., 539
thyrotoxicosis in adolescence, 543 ven den Hamer CJA, see Veen C et al., 549
ten Berge RJM, see de Wit R et al., 539 Vermylen J, see Renaud S et al., 79
Tengborn L, see Landin K et al., 181 Verstraete M, see Renaud §e t al., 79
Thaysen JH, Nielsen OJ, Brandi L & Szpirt W. Erythropoietin Vestergaard H, see Laurberg Pe t al., 415
deficiency in acute crescentic glomerulonephritis and in total Vesterqvist O, see Rasmanis G et al., 135
bilateral renal cortical necrosis, 363 Vivenzio A, see Fazio S et al., 41
Theodorsson E, see Gréndal S et al., 453
Thevenon C, see Renaud § et al., 79 Wakashin M, see Ogawa M et al., 189
Tiainen E, see Seppala T et al., 23 Wallberg-Jonsson S, see Nilsson TK et al., 558
Tiel-van Buul MMC, see Hollak CEM et al., 545 Wallin G, see Agewall S et al., 151
Tikkanen MJ, see Tilly-Kiesi M, 427 Wanecek M, see Ludwigs UG et al., 117
Tilly-Kiesi M & Tikkanen MJ. Low density lipoprotein density Widgren BR, Herlitz H, Jonsson O, Gerglund G, Wikstrand J &
and composition in hypercholesterolaemic men treated with Andersson OK. Normotensive young men with family
HMG CoA reductase inhibitors and gemfibrozil, 427 histories of hypertension gain weight and decrease their
Trojaborg W, see Ballegaard Se t al., 357 intraerythrocyte sodium content during a 5-year follow-up,
217
Ueda S, see Ogawa M et al., 189 Wikstrand J, see Widgren BR et al., 217
Urbinati G, see Fazio S et al., 41
Yamada M, see Mori M et al., 285
van der Valk P, see Oudkerk Pool M et al., 377 Yamaji Y, see Fujita J et al., 559
van der Wouw PA, see de Wit R et al., 539 Yamakido M, see Tanaka S et al., 371
Vazquez JJ, see Camacho J et al., 49 Yamamura Y, see Kraemer ES et al., 382
Veen C, ven den Hamer CJA & de Leeuw PW. Zinc sulphate Yamane K, see Tanaka Se t al., 371
therapy for Wilson's disease after acute deterioration during Yohannan MD, see Santhosh-Kumar CR et al., 493
treatment with low-dose D-penicillamine, 549
Veenhof CBN, see De Wit R et al., 35 Zamorano AF, see Camacho J et al., 49
Journal of Internal Medicine 1991; 229: 567-571
Subject Index
ACE inhibitor Atherosclerosis
effect on albuminuria and tubular transport functions, 163 and lipid levels, 483
ACTH 1-24 Atrial dilation
effect on hepatic lipase activity, 201 atrial fibrillation and, 253
Acupuncture Atrial fibrillation
in angina pectoris, 357 and atrial dilation, 253
Adenocarcinoma Atrial natriuretic peptide
and metastatic breast cancer, 463 response to low-pressure receptor activity, 151
Adrenaline peptide in dialysis patients, 209
and plasma chromogranin A+B, 453 Atrioventricular block
Adrenocortical insufficiency during exercise, 375
and Non-Hodgkin's lymphoma, 377 Autoimmune thyroiditis
Age effects of cigarette smoking on, 67
and platelet functions, 79 Autoimmunity
Agranulocytosis pancreatic function in Sjégren’s syndrome, 61
and long-term ibuprofen use, 281 in glomerulonephritis due to hydralazine treatment, 261
AIDS Autonomic nerve antibodies
-associated Kaposi's sarcoma, 35, 539 and autonomic nerve function, 505
prevention of salmonelloses in, 103 Autonomic neuropathy
Albuminuria and diabetes mellitus, 505
effects of lisinopril and nifedipine on, 163 AZT
Alcohol abuse and salmonelloses in AIDS patients, 103
predictive value of gamma-glutamyl! transferase, 497
Aluminium Bilateral adrenal tumours
and induction of severe osteomalacia, 275 in primary aldosteronism, 545
Anaemia Bile acids
serum erythropoietin levels in, 49 effect of cholestyramine on output rates, 241
and erythropoietin deficiency in renal failure, 363 Bleeding complications
Analgesics to oral anticoagulant therapy, 351
requirement in myocardial infarction, 257 Blood lipids
Angina pectoris effect of fish diet vs. meat diet, 317
acupuncture, in 357 Blood pressure
Antacids effect of recombinant erythropoietin treatment, 125
induction of osteomalacia, 275 effect of metformin treatment, 181
Anti-smooth muscle activities Blood screening
in Waldenstrém’s macroglobulinaemia, and survival in lung cancer patients, 337
Antibody activity Body weight
in Waldenstr6m’s macroglobulinaemia, 93 hypertension and sodium levels, 217
Anticoagulation Brain function
bleeding complications to oral therapy, 351 glycaemic thresholds for impairment of, 343
effect of dietary vitamin K, 517 Breast cancer
Antidiuretic hormone and adenocarcinoma, 463
diurnal variation in levels of, 131
Antioxidant therapy Caffeine
in congestive heart failure, 205 haemodynamic effects of, 501
Antithrombotic drugs Calcium
progress review, 113 levels in chronic heart failure, 171
Apathy Calcium antagonists
apathetic thyrotoxicosis, 543 effects on albuminuria and tubular transport functions, 163
Apolipoprotein B treatment of diabetics with felodipine, 233
gene alleles and the hypocholesterolaemic phenotype, 41 in severe chronic obstructive pulmonary disease, 447
levels in cerebellar ataxia and steatocystoma complex, Captopril
197 upregulation of calcium and phosphofructokinase, 171
Arginine vasopressin Cardiac output
levels in familial amyloidotic polyneuropathy, 55 as a paraneoplastic syndrome, 89
Ascites Carotid arteries
effects on bottom lines, 1 intima-media thickness of, 225
568 SUBJECT INDEX
Catecholamines counterregulatory hormonal response to hypoglycaemia
in pheochromocytoma patients, 453 in, 293
Cause of death renal artery stenosis in, 489
in unsuccessful prehospital resuscitation, 331 and autonomic nerve antibodies and function, 505
Cerebellar ataxia and left ventricular function, 527
familial hypobetalipoproteinaemia complicated by Diagnosis
Cerebral infarction of myocardial infarction, 143
and visual field defects, Diarrhoea
Cerebral ischaemia and prednisolone treatment, 443
and visual field defects, Diastolic heart function
Cerebrovascular disorders and failure, 479
serum creatinine as a predictor of survival, 175 Dietary fat
Chlamydia trachomatis and platelet function, 79
and dilated cardiomyopathy, 289 Digoxin
Cholestasis dosage in relation to kidney function, 247
during heparin therapy, 471 Dilated cardiomyopathy
Cholestatic jaundice and Chlamydia trachomatis infection, 289
cholesterol and phospholipid levels in, 17 Diurnal rhythm
Cholesterol in antidiuretic hormone levels, 131
effect of cholestyramine on output rate, 241 Double paraproteins
hypofibrinolysis and hypertension, 309 in Waldenstré6m’s macroglobulinaemia, 93
levels in post-infarction patients, 483 Drug development
Cholestyramine diversity in receptor signalling, 391
effect on biliary lipid secretion, 241 Drug therapy
Chromogranins and femoral neck fracture, 29
in pheochromocytoma patients, 453 antihypertensive, resistance to, 421
Chronic heart failure for thyrotoxicosis, 435
calcium and phosphofructokinase activity during Dysbetalipoproteinaemia
Citation frequency clearance of remnant lipoproteins in, 97
and journal impact, 109
Coagulation Echocardiography
effect of fish diet vs. meat diet, 317 and left atrial enlargement, 253
Coffee left ventricular function and wall thickness, 527
haemodynamic effects of, 501 Elastase antibodies
Cognitive function autoimmune responses in glomerulonephritis, 261
effect of intensified insulin treatment, 9 Electrocardiography
Collagenous colitis and exercise testing, 325
and prednisolone treatment, 443 Epidemiology
Congestive heart failure of thyrotoxicosis, 415
antioxidant therapy in, 205 Erythrocyte sedimentation rate
Coronary angiography and survival in lung cancer patients, 337
and exercise testing, 325 Erythropoietin
Coronary artery disease levels in the anaemia of chronic disorders, 49
prediction by exercise testing, 325 effect of haematological parameters, 125
and lipid levels, 483 deficiency in crescentic glomerulonephritis, 363
Counterregulatory hormones Etodolac
glycaemic thresholds for release of, 343 effects on the gastrointestinal mucosa, 5
Creatinine Exercise
clearance in relation to digoxin dosage, 247 and third-degree atrioventricular block, 375
Crescentic glomerulonephritis Exercise testing
erythropoietin deiiciency in, 363 degree of coronary artery disease predicted by, 325
Cryoglobulin
in Waldenstr6m’s macroglobulinaemia, 93 Familial amyloidosis
assessment of hypothalamic pituitary function in, 55
D-penicillamine Familial hypercholesterolaemia
treatment for Wilson’s disease, 549 HMG CoA reductase inhibitors and gemfibrozil, 427
Depression Familial hypobetalipoproteinaemia
and central hypothyroidism, 285 complicated by cerebellar ataxia and steatocystoma multiplex,
Diabetes mellitus 197
dysbetalipoproteinaemia in, 97 Family studies
effects of lisinopril and nifedipine in, 163 of hypobetalipoproteinaemia, 41
and carotid intima-media thickness, 225 Fatty acids
treatment with felodipine, 233 and platelet function, 79
mild fasting hypertriglyceridaemia in, 267 and hypertriglyceridaemia in diabetes, 267
SUBJECT INDEX 569
Felodipine Hepatic lipase
in treatment of hypertensive type II diabetics, 233 effect of ACTH 1-24, 201
effects on haemorheology in hypertension, 533 HMG CoA reductase inhibitors
Femoral neck fracture to treat familial hypercholesterolaemia, 427
drug use and, 29 Hodgkin's disease
Ferritin and osteomyelitis of the wrist, 467
effect of recombinant human erythropoietin on, 125 Hydralazine
Fibrinolysis autoimmune responses in glomerulonephritis due to, 261
effect of fish diet vs. meat diet, 317 Hydrochlorothiazide
Fibrosing adveolitis comparison with felodipine ER in hypertension, 533
induction by sulphasalazine, 553 Hypersensitivity pneumonitis
Fish diet induction by sulphasalazine, 553
effect on blood lipids, coagulation and fibrinolysis, 317 Hypertension
and ischaemic heart disease, 511] metformin treatment of insulin resistance in, 181
body weight and sodium content, 217
G-proteins hypofibrinolysis in patients with, 309
and receptor signalling, 391 resistance to drug therapy, 421
Gamma-glutamyl transferase effects of felodipine ER in, 533
positive predictive value for alcohol abuse, 497 Hyperthyroidism
Gastric mucosal lesions thyroid-related hormones and goitre, 407
effects of etodolac and naproxen on, 5 Hypertriglyceridaemia
Gemfibrozil in non-insulin-dependent diabetes, 267
to treat familial hypercholesterolaemia, 427 Hypervagotonia
Glomerulonephritis and exercise, 375
autoimmune responses in, 261 Hypobetalipoproteinaemia
Glucose tolerance not due to a mutation in the apo B gene, 41
effect of felodipine in diabetics, 233 Hypofibrinolysis
Glycaemic thresholds hypertension and cholesterol levels, 309
for impairment of cognitive function, 343 Hypogammaglobulinaemia
Glycoproteins subcutaneous IgG substitution, 73
breast cancer and adenocarcinoma, 463 Hypoglycaemia
Goitre during intensified insulin treatment, 9
effects of cigarette smoking on, 67 counterregulatory hormonal response to, 293
variation in assessment of, 159 and impairment of cognitive function, 343
thyroid-related hormones and, 407 Hypothalamic-pituitary regulation
and iodine intake, 415 in familial amyloidotic polyneuropathy, 55
Granulocytopenia Hypothyroidism
gastric lymphoma causing, 193 due to isolated TRH deficiency, 285
Graves’ disease thyroid-related hormones and goitre, 407
and iodine intake, 415 and thyrotoxicosis, 435
Graves’ thyrotoxicosis
incidence of recurrence and hypothyroidism, 435 Ibuprofen
Growth hormone severe thrombocytopenia caused by, 281
regulation in familial amyloidotic polyneuropathy, 55 Infection
serum erythropoietin levels during, 49
Haemodialysis Inflammation
atrial natriuretic peptide during, 209 serum erythropoietin levels during, 49
haemodynamic effects Insulin
of coffee and caffeine, 501 role in dysbetalipoproteinaemia, 97
Haemoglobin counterregulatory hormonal response to hypoglycaemia,
effect of human erythropoietin on, 125 293
Haemolytic anaemia Insulin resistance
and long-term ibuprofen use, 281 metformin treatment in hypertension, 181
Haemorheology and hypertriglyceridaemia in diabetes, 267
impairment after stroke, 457 Insulin treatment
effects of felodipine ER in hypertension, 533 hypoglycaemic episodes during, 9
HDL cholesterol Interferon-alpha
levels in viral hepatitis and cholestatic jaundice, 17 treatment in AIDS-associated Kaposi’s sarcoma, 35, 539
Heart rate Interleukin-6
effect of recombinant human erythropoietin on, 125 and AIDS-associated Kaposi's sarcoma, 539
Heparin therapy Iodine
cholestasis during, 471 intake, toxic goitre and Graves’ disease, 415
Heparin-precipitable protein Ion channels
in gastric lymphoma causing granulocytopenia, 193 and receptor signalling, 391
570 SUBJECT INDEX
Iradipine Neurological diseases
in severe chronic obstructive pulmonary disease mechanical ventilation in, 117
Ischaemic heart disease Neuropeptide Y
and fish consumption, 511 in pheochromocytoma patients, 453
Islet cell antibodies Nifedipine
in Sjégren’s syndrome, 61 effect on albuminuria and tubular transport functions, 163
Non-Hodgkin's lymphoma
Journal impact and adrenocortical insufficiency, 377
and citation frequency, 109 NP59 scan
localization of a unilateral aldosteronoma, 545
Kaposi’s sarcoma
AIDS-associated, treatment of, 35 Obesity
treatment with interferon-alpha, 539 and hypertriglyceridaemia in diabetes, 267
Ketotifen television viewing and life style, 301
efficacy in systemic mastocytosis, 475 and antihypertensive drug therapy, 421
Kidney function Observer variation
digoxin dosage in relation to, 247 in clinical assessment of thyroid gland, 159
Obstructive lung disease
Left ventricular function effect of isradipine on, 447
in diabetes mellitus, 527 Osteomalacia
Leucocytes induced by antacid, 275
effect of recombinant human erythropoietin, 125 Osteomyelitis
Lipoproteins and Hodgkin's disease, 467
and carotid intima-media thickness, 225
Lisinopril Pain
effect on albuminuria and tubular transport functions, 163 and antihypertensive drug therapy, 421
Liver function tests Palpation
and heparin therapy, 471 in assessment of thyroid gland, 159
Low density lipoprotein Pancreatic function
effect of ACTH 1-24 on, 201 exocrine, in Sjogren's syndrome, 61
in familial hypercholesterolaemia, 427 Paraneoplastic syndrome
Low-pressure receptors high cardiac output as a, 89
neuronal and humoral responses to stimulation of, 151 Pheochromocytoma
Lung neoplasms associated with meningioma, 371
blood screening and survival, 337 chromogranins, neuropeptide Y and catecholamines in, 453
Lymphoma Phosphofructokinase
high cardiac output in, 89 levels in chronic heart failure, 171
Phospholipids
Malignant lymphoma levels in viral hepatitis and cholestatic jaundice, 17
causing granulocytopenia and cold intolerance, 193 effect of cholestyramine on output rates, 241
Meat diet Physical disability
effect on blood lipids, coagulation and fibrinolysis, 317 and recent drug use, 29
Mechanical ventilation Plasma lipids
in medical and neurological diseases, 117 and platelet function, 79
Medical diseases Plasma renin
mechanical ventilation in, 117 activity during haemodialysis, 209
Meningioma Plasminogen activator inhibitor
cvheochromocytoma associated with, 371 hypertension and cholesterol levels, 309
Monoclonal antibodies Platelet activity
breast cancer and adenocarcinoma, 463 relationship to age and dietary habits, 79
Myeloperoxidase antibodies and long-term diet modification, 511
autoimmune responses in glomerulonephritis, 261 Pneumothorax
Myocardial infarction in Wegener's granulomatosis, 189
prostacyclin production in, 135 Prednisolone
rapid and correct diagnosis of, 143 to treat collagenous colitis, 443
reduction of analgesic requirement in, 257 Prehospital care
Myocarditis and cause of death, 331
and Chlamydia trachomatis infection, 289 Primary aldosteronism
bilateral adrenal tumours in, 545
Naproxen Prognosis
effects on the gastrointestinal mucosa, 5 and mechanical ventilation, 117
Neoplasia Prolactin
serum erythropoietin levels during, 49 regulation in familial and amyloidotic polyneuropathy, 55
Nephropathy Prostacyclin
effects of lisinopril and nifedipine in diabetics with, 163 production in myocardial infarction, 135